Trial Profile

The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women With Breast Cancer Following Initiation of Aromatase Inhibitor Therapy

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Risedronic acid (Primary)
Indications Postmenopausal osteoporosis
Focus Biomarker; Therapeutic Use
Acronyms REBBeCA-II

Most Recent Events

06 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
06 Oct 2013 Primary endpoint 'Lumbar-spine-bone-mineral-density' has been met.
06 Oct 2013 Primary endpoint 'Hip-bone-mineral-density' has been met.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com